MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Lantheus Holdings Inc

Suletud

SektorTervishoid

101.64 -1.79

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

100.72

Max

101.64

Põhinäitajad

By Trading Economics

Sissetulek

-143M

-12M

Müük

12M

391M

P/E

Sektori keskmine

23.078

57.333

Aktsiakasum

1.59

Kasumimarginaal

-3.014

Töötajad

808

EBITDA

-177M

22M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+24.92% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. mai 2025

Turustatistika

By TradingEconomics

Turukapital

1.5B

7B

Eelmine avamishind

103.43

Eelmine sulgemishind

101.64

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Lantheus Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. apr 2025, 17:01 UTC

Tulu
Suurimad hinnamuutused turgudel

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

25. apr 2025, 16:10 UTC

Tulu
Suurimad hinnamuutused turgudel

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

26. apr 2025, 18:14 UTC

Tulu

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

26. apr 2025, 15:00 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

26. apr 2025, 11:00 UTC

Peamised uudised

America's Leather Economy Has Gone Global, and Now It Can't Escape the Trade War -- WSJ

26. apr 2025, 08:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

26. apr 2025, 03:00 UTC

Peamised uudised

The Chinese Satellite Firm Washington Accuses of Helping U.S. Foes -- WSJ

25. apr 2025, 21:24 UTC

Peamised uudised

Cargo Shipments From China to the U.S. Dwindle -- WSJ

25. apr 2025, 20:50 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

25. apr 2025, 20:45 UTC

Peamised uudised

Stocks Claw Back Most of April's Tariff Losses -- WSJ

25. apr 2025, 20:39 UTC

Tulu

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

25. apr 2025, 20:37 UTC

Peamised uudised

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

25. apr 2025, 20:19 UTC

Peamised uudised

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

25. apr 2025, 20:15 UTC

Tulu

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

25. apr 2025, 19:23 UTC

Market Talk

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

25. apr 2025, 19:18 UTC

Market Talk

Oil Futures End Choppy Week With Losses -- Market Talk

25. apr 2025, 18:47 UTC

Market Talk

Gold Extends Pullback to Close Week -- Market Talk

25. apr 2025, 18:39 UTC

Peamised uudised

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

25. apr 2025, 18:34 UTC

Omandamised, ülevõtmised, äriostud

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

25. apr 2025, 18:32 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

25. apr 2025, 18:32 UTC

Market Talk
Tulu

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

25. apr 2025, 18:08 UTC

Tulu

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

25. apr 2025, 17:55 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

25. apr 2025, 17:40 UTC

Peamised uudised

Consumers Continue to Sour on the Economy -- 4th Update

25. apr 2025, 17:38 UTC

Tulu

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

25. apr 2025, 17:07 UTC

Market Talk

Oil Futures Turn Higher in Quiet Trade -- Market Talk

25. apr 2025, 16:54 UTC

Market Talk
Tulu

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

25. apr 2025, 16:46 UTC

Tulu

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

25. apr 2025, 16:20 UTC

Market Talk
Tulu

Basic Materials Roundup: Market Talk

25. apr 2025, 16:12 UTC

Peamised uudised

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

Võrdlus sarnastega

Hinnamuutus

Lantheus Holdings Inc Prognoos

Hinnasiht

By TipRanks

24.92% tõus

12 kuu keskmine prognoos

Keskmine 127.13 USD  24.92%

Kõrge 140 USD

Madal 110 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Lantheus Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

9 ratings

8

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

100.48 / 104Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.